Rapporten

Djupdykningar i företagsfinansiering, tillväxtstrategier och marknadsinsikter från världens mest innovativa företag

208 rapporter och fler

Uppdateras dagligen med senaste marknadsintelligens
Fundraising
4D Molecular Therapeutics

4D Molecular Therapeutics Raises $105M in Series D

4D Molecular Therapeutics, a Biotech company based in 5858 Horton Street, Emeryville, CA 94608, has raised $105M in Series D at a $800M valuation led by Versant Ventures, Foresite Capital, Viking Global Investors, Fidelity.

Fundraising News Team
May 27, 2024
0 min read
Biotech
4D Molecular Therapeutics

4D Molecular Therapeutics raises $105M Series D at $800M valuation

4D Molecular Therapeutics raises $105M in Series D at $800M valuation. Targeted gene therapy vectors...

Editorial Team
May 27, 2024
0 min read$105M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read$400M
Biotech
Expedition Therapeutics

Expedition Therapeutics raises $165M Series B at $850M valuation

Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...

Editorial Team
Jan 15, 2025
0 min read$165M
Sida 1

Visar 9 rapporter • Sida 1 • Kategori: all

Ligga steget före marknaden

Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.